them, polymyositis (PM) and dermatomyositis (DM) show the most prominent muscular symptoms. Previously, both diseases were considered simply to be varieties of the identical disease, and sometimes PM/DM syndrome was used as an inclusive term. But today, the difference between the two is clear immunplogically as well as pathologically. Although striated muscle is the main target of the autoimmunemechanismin both, in DM,the intramuscular small blood vessels are more dominant effector sites, while in PM,the muscle fibers are more direct targets. Occlusions of arterioles and the resultant necrosis of the muscle fibers,immune complexes of immunoglobulins and complement C3 in the perimysial venules, and MAC (membrane attack complex of complement) neoantigen have been reported. Andmore recently, changes in the vascular components were proven to be the primary lesion in this disease because microtubular inclusions and microvacuoles in endomysial capillaries and MACdeposits with an anti-MAC antibody were recognized even in otherwise normal muscle of patients with DM(1, 2). It is well knownthat complications in organs or tissues other than muscle and skin are frequent in this disease,and such lesions have also been attributed to vascular pathology. In this issue of the Journal, Matsuda et al reported a case with DM accompanied by splenic and renal infarction (3).
See also p 512.
As the authors indicated, these complications have been considered to be very rare especially in adults, but this combination is not likely coincidental even though administration of adrenal cortical steroids played some role in evoking such infarctions. Such cases might suggest a possibility that a more generalized autoimmune mechanisminvolving the vascular system is present in DM.The demonstration of circulating antibody to humanumbilical vein endothelial cells in patients with DMassociated with interstitial lung disease (4) 
